| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Department of Molecular Medicine, Karolinska Institute, S-17176 Stockholm, Sweden [T. L., A. L.]; Howard Hughes Medical Institute and Johns Hopkins Oncology Center, Baltimore, Maryland 21231 [H. Y., K. W. K., B. V.]; Department of Medical Genetics, Haartman Institute, University of Helsinki, Helsinki, Finland [S. K.]; Department of Internal Medicine, University of Modena, 41100 Modena, Italy [A. P., M. P., P. B., M. P. d. L.]; Danish Polyposis Register, Hvidover University Hospital, DK-2100 Copenhagen, Denmark [M-L. B.]; and Human Cancer Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210 [P. P.]
Hereditary nonpolyposis colorectal cancer (HNPCC) is attributable to a deficiency of mismatch repair. Inactivation of DNA mismatch repair underlies the genesis of microsatellite instability in colorectal cancer. Germline mutations in three DNA mismatch repair genes, hMSH2, hMLH1, and hMSH6, have been found to segregate in HNPCC and HNPCC-like families. The two DNA mismatch repair genes hPMS1 and hPMS2 have also been suggested to predispose to HNPCC. In this study, 84 HNPCC and HNPCC-like kindreds without known mutations in the other three known DNA mismatch repair genes were screened for germline mutations in the hPMS1 or hPMS2 gene. No clear-cut pathogenic mutations were identified. Conversion technology was used to detect a large hMSH2 deletion in two affected members of the kindred in which the hPMS1 mutation was originally reported, whereas the hPMS1 mutation was only present in one of these two individuals. Since the hPMS1 and hPMS2 genes were first reported, germline mutations in hPMS2 have been demonstrated primarily in patients with Turcot’s syndrome. However, no mutation in any of the two genes has been found to segregate in HNPCC families. Until there is better evidence for an increased colorectal cancer risk associated with germline mutations in these genes, a conservative interpretation of the role of mutations in these genes is advised.
This article has been cited by other articles:
|
|
 |
|
  M Clendenning, L Senter, H Hampel, K L. Robinson, S Sun, D Buchanan, M D Walsh, M Nilbert, J Green, J Potter, et al. A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome J. Med. Genet., June 1, 2008; 45(6): 340 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Lagerstedt Robinson, T. Liu, J. Vandrovcova, B. Halvarsson, M. Clendenning, T. Frebourg, N. Papadopoulos, K. W. Kinzler, B. Vogelstein, P. Peltomaki, et al. Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics J Natl Cancer Inst, February 21, 2007; 99(4): 291 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M.C. Hendriks, A. E. de Jong, H. Morreau, C. M.J. Tops, H. F. Vasen, J. Th. Wijnen, M. H. Breuning, and A. H.J.T. Brocker-Vriends Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians CA Cancer J Clin, July 1, 2006; 56(4): 213 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Woods, A. J. Hyde, F. K. Curtis, S. Stuckless, J. S. Green, A. F. Pollett, J. D. Robb, R. C. Green, M. E. Croitoru, A. Careen, et al. High Frequency of Hereditary Colorectal Cancer in Newfoundland Likely Involves Novel Susceptibility Genes Clin. Cancer Res., October 1, 2005; 11(19): 6853 - 6861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gill, N. M. Lindor, L. J. Burgart, R. Smalley, O. Leontovich, A. J. French, R. M. Goldberg, D. J. Sargent, J. R. Jass, J. L. Hopper, et al. Isolated Loss of PMS2 Expression in Colorectal Cancers: Frequency, Patient Age, and Familial Aggregation Clin. Cancer Res., September 15, 2005; 11(18): 6466 - 6471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Stormorken, I. M. Bowitz-Lothe, T. Noren, E. Kure, S. Aase, J. Wijnen, J. Apold, K. Heimdal, and P. Moller Immunohistochemistry Identifies Carriers of Mismatch Repair Gene Defects Causing Hereditary Nonpolyposis Colorectal Cancer J. Clin. Oncol., July 20, 2005; 23(21): 4705 - 4712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Casey, N. M. Lindor, N. Papadopoulos, S. N. Thibodeau, J. Moskow, S. Steelman, C. H. Buzin, S. S. Sommer, C. E. Collins, M. Butz, et al. Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer JAMA, February 16, 2005; 293(7): 799 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Garber and K. Offit Hereditary Cancer Predisposition Syndromes J. Clin. Oncol., January 10, 2005; 23(2): 276 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yuan, Y.-q. Huang, S.-r. Cai, Y.-m. Song, S. Zheng, and S.-z. Zhang Genetic Characterization of Chinese Hereditary Non-polyposis Colorectal Cancer by DHPLC and Multiplex PCR Jpn. J. Clin. Oncol., November 1, 2004; 34(11): 660 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Luo, F.-T. Lin, and W.-C. Lin ATM-Mediated Stabilization of hMutL DNA Mismatch Repair Proteins Augments p53 Activation during DNA Damage Mol. Cell. Biol., July 15, 2004; 24(14): 6430 - 6444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nakagawa, J. C. Lockman, W. L. Frankel, H. Hampel, K. Steenblock, L. J. Burgart, S. N. Thibodeau, and A. de la Chapelle Mismatch Repair Gene PMS2: Disease-Causing Germline Mutations Are Frequent in Patients Whose Tumors Stain Negative for PMS2 Protein, but Paralogous Genes Obscure Mutation Detection and Interpretation Cancer Res., July 15, 2004; 64(14): 4721 - 4727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Ponz de Leon, P Benatti, F Borghi, M Pedroni, A Scarselli, C Di Gregorio, L Losi, A Viel, M Genuardi, G Abbati, et al. Aetiology of colorectal cancer and relevance of monogenic inheritance Gut, January 1, 2004; 53(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gazzoli and R. D. Kolodner Regulation of the Human MSH6 Gene by the Sp1 Transcription Factor and Alteration of Promoter Activity and Expression by Polymorphisms Mol. Cell. Biol., November 15, 2003; 23(22): 7992 - 8007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Renkonen, Y. Zhang, H. Lohi, R. Salovaara, W. M. Abdel-Rahman, M. Nilbert, K. Aittomaki, H. J. Jarvinen, J.-P. Mecklin, A. Lindblom, et al. Altered Expression of MLH1, MSH2, and MSH6 in Predisposition to Hereditary Nonpolyposis Colorectal Cancer J. Clin. Oncol., October 1, 2003; 21(19): 3629 - 3637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Plotz, J. Raedle, A. Brieger, J. Trojan, and S. Zeuzem N-terminus of hMLH1 confers interaction of hMutL{alpha} and hMutL{beta} with hMutS{alpha} Nucleic Acids Res., June 15, 2003; 31(12): 3217 - 3226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H J Jarvinen Genetic testing for polyposis: practical and ethical aspects Gut, May 1, 2003; 52(90002): ii19 - 22. [Abstract] [Full Text]
|
|
|
|
|
|
P. Peltomaki Role of DNA Mismatch Repair Defects in the Pathogenesis of Human Cancer J. Clin. Oncol., March 15, 2003; 21(6): 1174 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kucherlapati, K. Yang, M. Kuraguchi, J. Zhao, M. Lia, J. Heyer, M. F. Kane, K. Fan, R. Russell, A. M. C. Brown, et al. Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor progression PNAS, July 23, 2002; 99(15): 9924 - 9929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Wahlberg, J. Schmeits, G. Thomas, M. Loda, J. Garber, S. Syngal, R. D. Kolodner, and E. Fox Evaluation of Microsatellite Instability and Immunohistochemistry for the Prediction of Germ-Line MSH2 and MLH1 Mutations in Hereditary Nonpolyposis Colon Cancer Families Cancer Res., June 1, 2002; 62(12): 3485 - 3492. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
